Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Akura Medical, a Shifamed Portfolio Company

Akura Medical, a Shifamed Portfolio Company

Series CUS
Facts
Year of incorporation
unknown
Revenue range (Form D)
unknown
Rounds on record
1
Disclosed raised
$53.0Msum of rounds with a disclosed amount only
Named investors
1
Financing history
1 rounds
  1. Dec 1, 2025
    Series C · $53.0M (disclosed)
    Qatar Investment Authority (lead)
    Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) · “Akura Medical, a Shifamed Portfolio Company, Closes $53 Million in Series C Financing”
Investors on record
1 edges
People
0 officers, 0 directors
No officer or director on record.
Timeline
1
  1. Dec 1, 2025
    Akura Medical, a Shifamed Portfolio Company announced Series C of $53,000,000, led by Qatar Investment Authority
    Round announced Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
Evidence
1 observations
Every observation on this company